Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

BOM/544529 stock hub

BOM/544529 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/544529is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/544529

In the news

Latest news · BOM/544529

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E54.6

P25 n/aP50 n/aP75 n/a

ROE30.5

P25 n/aP50 n/aP75 n/a

ROIC22.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/544529 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

INR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	70
Enterprise value	INR 3B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	INR 2.9B
Price	INR 425
Price currency	INR
Rev Per Employee	6,653,514.29x
Sic	5122
Symbol	bom/544529
Website	https://aptus-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.58%
EV Earnings	64.44x
EV/EBIT	42.29x
EV/EBITDA	39.97x
EV/FCF	-32.91x
EV/Sales	6.39x
FCF yield	-3.1%
P/B ratio	12.49x
P/E ratio	54.63x
P/S ratio	6.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.11%
EBITDA Margin	15.99%
Gross margin	54.12%
Gross Profit	INR 252M
Gross Profit Growth	50.3%
Gross Profit Growth Q	94.56%
Gross Profit Growth3 Y	55.71%
Net Income	INR 46.2M
Net Income Growth	437.25%
Net Income Growth Q	60.14%
Net Income Growth3 Y	257.87%
Pretax Margin	13.69%
Profit Margin	9.92%
Profit Per Employee	INR 659,986
ROA	13.44
Roa5y	10.46
ROCE	29.05
ROE	30.48
Roe5y	40.31
ROIC	22.65
Roic5y	21.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	35.73
EPS Growth Q	111.2
EPS Growth3 Y	77.98
Revenue Growth	160.82x
Revenue Growth Q	117.52x
Revenue Growth3 Y	64.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.42
Assets	INR 435.3M
Cash	INR 10.3M
Current Assets	INR 352.4M
Current Liabilities	INR 193.1M
Debt	INR 71.8M
Debt EBITDA	INR 0.96
Debt Equity	INR 0.31
Debt FCF	INR -0.79
Equity	INR 233.5M
Interest Coverage	8.82
Liabilities	INR 201.9M
Long Term Assets	INR 83M
Long Term Liabilities	INR 8.8M
Net Cash	INR -61.5M
Net Cash By Market Cap	INR -2.11
Net Debt EBITDA	INR 0.83
Net Debt Equity	INR 0.26
Tangible Book Value	INR 232.9M
Tangible Book Value Per Share	INR 34.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.83
Inventory Turnover	2.07
Net Working Capital	INR 215.6M
Quick ratio	1.02
Working Capital	INR 159.3M
Working Capital Turnover	INR 2.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-295.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	328.3
All Time High	446.8
All Time High Change	-4.88%
All Time High Date	2026-05-07
All Time Low	80.8
All Time Low Change	425.99%
All Time Low Date	2025-09-30
ATR	12.04
Beta1y	-0.25
Ch YTD	150.7
High	436.5
High52	446.8
High52 Date	2026-05-07
High52ch	-4.88%
Low	423.5
Low52	80.8
Low52 Date	2025-09-30
Low52ch	425.99%
Ma50ch	29.45%
RSI	70.32
RSI Monthly	0
RSI Weekly	93.42
Sharpe ratio	5.96x
Sortino ratio	12.6
Total Return	-295.83%
Tr YTD	150.7
Tr1m	21.12%
Tr1w	4.04%
Tr3m	72.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 70.4M
Operating Income Growth	39.41
Operating Income Growth Q	52.13
Operating Income Growth3 Y	209.5
Operating margin	15.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,476,000%
Net Borrowing	-31,781,000
Shares Insiders	72.89%
Shares Institutions	6.38%
Shares Out	6,860,000
Shares Qo Q	0%
Shares Yo Y	295.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -90.5M
Average Volume	7,400x
Bv Per Share	34.2
CAPEX	INR -21.9M
Ch1m	21.12
Ch1w	4.04
Ch3m	72.27
Ch6m	192.1
Change	-4.49%
Change From Open	-2.63
Close	445
Days Gap	-1.91
Depreciation Amortization	4,080,000
Dollar Volume	4,250,000
Earnings Date	2026-04-27
EBIT	INR 70.4M
EBITDA	INR 74.5M
EPS	INR 7.78
F Score	3
FCF	INR -90.5M
FCF EV Yield	-3.04x
FCF Per Share	INR -13.19
Financing CF	90,437,000
Fiscal Year End	March
Founded	2,010
Graham Number	77.37863
Graham Upside	-82.61
Income Tax	INR 17.5M
Investing CF	-63,711,000
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Lynch Fair Value	INR 195
Lynch Upside	-56.29
Ma20	386.1
Ma20ch	10.06%
Net CF	-41,872,000
Next Earnings Date	2026-06-19
Open	436.5
Position In Range	11.54
Ppne	27,141,000
Price Date	2026-05-08
Price EBITDA	INR 39.15
Ptbv Ratio	12.52
Relative Volume	1.35x
Revenue	465,746,000x
Tax By Revenue	3.77x
Tax Rate	27.53%
Tr6m	192.1%
Volume	10,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/544529 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BOM/544529?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.4%

Share of float held by funds and institutions

Insider ownership

+72.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+295.8%

Negative means the company is buying back shares.

Technical

BOM/544529 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.3

Above 70: short-term overbought

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

5.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/544529

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/544529 stock rating?

bom/544529 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/544529 analysis?

The full report lives at /stocks/bom/544529/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/544529?

The latest report frames bom/544529 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/544529 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.